Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06027905 · ClinicalTrials.gov registry record · NA
Novartis - Closing the Gap in Cardiovascular Risk: Engage, Empower, Evaluate
A NA study of Hypertension, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 445
- Enrollment target
- 1
- Study location
NCT06027905: Completed NA study of Hypertension, sponsored by Rush University Medical Center.
NCT06027905 is a NA study of Hypertension that has completed, run by Rush University Medical Center. The registered enrollment target is 445 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06027905, a NA study of Hypertension, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 445 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to decrease the racial gap in high blood pressure in African American and Latinx patients in Rush University Medical Center clinics.
Primary Outcome
Percentage of total participants with improvement from stage II hypertension (140/90 mmHg or above) to blood pressure below 130/80 mmHg with home cuff through self monitoring
Conditions Studied
Interventions
- OTHER E3 Remote Monitoring and Social Intervention
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2023-09-13 |
| Est. Completion | 2025-05-12 |
| Phase | NA |
What the finished NCT06027905 record still lists
NCT06027905 is an interventional study that assigns participants to a tested intervention. The registered 445 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which E3 Remote Monitoring and Social Intervention is the first listed.
NCT06027905 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06027905 about?
NCT06027905 is a clinical study titled "Novartis - Closing the Gap in Cardiovascular Risk: Engage, Empower, Evaluate". This study aims to decrease the racial gap in high blood pressure in African American and Latinx patients in Rush University Medical Center clinics.
What is the current status of trial NCT06027905?
This trial is currently completed. It is a NA study. The enrollment target is 445 participants. The study started on 2023-09-13. Estimated completion is 2025-05-12.
What conditions does trial NCT06027905 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT06027905?
The interventions under investigation include: E3 Remote Monitoring and Social Intervention (OTHER).
Who is sponsoring clinical trial NCT06027905?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06027905 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06027905's enrollment target sits among peer trials
445 137th of 470 higher than 333 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI